<?xml version='1.0' encoding='utf-8'?>
<document id="23731657"><sentence text="In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein." /><sentence text="Concomitant administration of herbal medicines with drugs that are P-glycoprotein (P-gp) substrates may produce significant herb-drug interactions" /><sentence text=" The purpose of this study was to evaluate the effects of Schisandra lignans extract (SLE) on P-gp thoroughly in vitro and in vivo, and to investigate the possible P-gp-based herb-drug interactions" /><sentence text=" In the in vitro experiments, the effect of SLE on the uptake and transport for P-gp substrates in Caco-2, LLC-PK1 and L-MDR1 cells were carefully investigated" /><sentence text=" Verapamil, a known P-gp inhibitor, was used as a positive control drug" /><sentence text=" Results shown that, 10 μM verapamil and SLE (0" /><sentence text="5, 2" /><sentence text="0, and 10" /><sentence text="0 μg/ml) were observed to significantly enhance the uptake and inhibit the efflux ratio of P-gp substrates in Caco-2 and L-MDR1 cells" /><sentence text=" In vivo experiments showed that single-dose SLE at 500 mg/kg could increase the area under the plasma concentration time curve of digoxin and vincrisine significantly without affecting terminal elimination half-time"><entity charOffset="131-138" id="DDI-PubMed.23731657.s10.e0" text="digoxin" /><entity charOffset="143-153" id="DDI-PubMed.23731657.s10.e1" text="vincrisine" /><pair ddi="false" e1="DDI-PubMed.23731657.s10.e0" e2="DDI-PubMed.23731657.s10.e0" /><pair ddi="false" e1="DDI-PubMed.23731657.s10.e0" e2="DDI-PubMed.23731657.s10.e1" /></sentence><sentence text=" Long-term treatment with SLE for continuous 10 days could also increase the absorption of P-gp substrates with greatly down regulation of P-gp expression in rat intestinal and brain tissues" /><sentence text=" In conclusion, SLE was a strong P-gp inhibitor, which indicated a potential herb-drug interaction when SLE was co-administered with P-gp substrate drugs" /><sentence text="" /></document>